Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 12Rectal Neoplasms 5Urinary Bladder Neoplasms 4Pancreatic Neoplasms 4Neoplasms 4Esophageal Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Stomach Neoplasms 3Recurrence 3Ovarian Neoplasms 3Colorectal Neoplasms 3Carcinoma, Hepatocellular 3Uterine Cervical Neoplasms 2Postoperative Complications 2Pathologic Complete Response 2Head and Neck Neoplasms 2Breast Cancer Patients 2Surgery 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Salivary Gland Neoplasms 1Radiation Injuries 1QOL; Quality of Life;Gastric Cancer; Gastrectomy;Neoadjuvant Chemotherapy 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Peritoneal Neoplasms 1Oropharyngeal Neoplasms 1Neoplastic Cells, Circulating 1Neoplasm, Residual 1Neoplasm Metastasis 1Neoadjuvant Chemotherapy 1

Interventions

Neoadjuvant Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Locally Advanced Rectal Cancer × Neoadjuvant Therapy × Clear all
NCT03699410 2021-10-13

LiBReCa

Ente Ospedaliero Cantonale, Bellinzona

Terminated
25 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡